ENVISTA HOLDINGS CORPORATION Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation
ENVISTA HOLDINGS CORPORATION (NVST) reported Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation of $400.00 thousand for the 9-month period ending 2023-09-29, per its 10-Q filed 2023-11-01.
Discontinued › Notes
us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation · last filed 2023-11-01
- ENVISTA HOLDINGS CORPORATION financing receivable, allowance for credit loss, foreign currency translation for the quarter ending 2023-09-29 was $200.00K, a 66.67% decline year-over-year.
- ENVISTA HOLDINGS CORPORATION financing receivable, allowance for credit loss, foreign currency translation for the quarter ending 2023-06-30 was $400.00K, a 63.64% decline year-over-year.
- ENVISTA HOLDINGS CORPORATION financing receivable, allowance for credit loss, foreign currency translation for the quarter ending 2023-03-31 was -$200.00K.
- ENVISTA HOLDINGS CORPORATION financing receivable, allowance for credit loss, foreign currency translation for the quarter ending 2022-12-31 was -$700.00K, a 200.00% decline year-over-year.
- ENVISTA HOLDINGS CORPORATION financing receivable, allowance for credit loss, foreign currency translation for fiscal 2022 was $800.00K, a 46.67% decline from fiscal 2021.
- ENVISTA HOLDINGS CORPORATION financing receivable, allowance for credit loss, foreign currency translation for fiscal 2021 was $1.50M.
- ENVISTA HOLDINGS CORPORATION financing receivable, allowance for credit loss, foreign currency translation for fiscal 2020 was -$400.00K.
| Period end | Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation 3 month | Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation 6 month | Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation 9 month | Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation 12 month |
|---|---|---|---|---|
| 2023-09-29 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $600.00K derived: sum of 2 quarters · filed 2023-11-01 | $400.00K 10-Q · filed 2023-11-01 | -$300.00K derived: sum of 4 quarters · filed 2023-11-01 |
| 2023-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $200.00K 10-Q · filed 2023-08-02 | -$500.00K derived: sum of 3 quarters · filed 2023-08-02 | $100.00K derived: sum of 4 quarters · filed 2023-08-02 |
| 2023-03-31 | -$200.00K 10-Q · filed 2023-05-03 | -$900.00K derived: sum of 2 quarters · filed 2023-05-03 | -$300.00K derived: sum of 3 quarters · filed 2023-05-03 | $800.00K derived: sum of 4 quarters · filed 2023-05-03 |
| 2022-12-31 | -$700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$100.00K derived: sum of 2 quarters · filed 2023-02-16 | $1.00M derived: sum of 3 quarters · filed 2023-02-16 | $800.00K 10-K · filed 2023-02-16 |
| 2022-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.70M derived: sum of 2 quarters · filed 2022-11-03 | $1.50M 10-Q · filed 2022-11-03 | $2.20M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-07-01 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $900.00K 10-Q · filed 2022-08-03 | $1.60M derived: sum of 3 quarters · filed 2022-08-03 | $1.90M derived: sum of 4 quarters · filed 2022-08-03 |
| 2022-04-01 | -$200.00K 10-Q · filed 2022-05-04 | $500.00K derived: sum of 2 quarters · filed 2022-05-04 | $800.00K derived: sum of 3 quarters · filed 2022-05-04 | $400.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2021-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.00M derived: sum of 2 quarters · filed 2022-02-24 | $600.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.50M 10-K · filed 2022-02-24 |
| 2021-10-01 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$100.00K derived: sum of 2 quarters · filed 2021-11-03 | $800.00K 10-Q · filed 2021-11-03 | $800.00K derived: sum of 4 quarters · filed 2021-11-03 |
| 2021-07-02 | -$400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $500.00K 10-Q · filed 2021-08-03 | $500.00K derived: sum of 3 quarters · filed 2021-08-03 | $800.00K derived: sum of 4 quarters · filed 2021-08-03 |
| 2021-04-02 | $900.00K 10-Q · filed 2021-05-05 | $900.00K derived: sum of 2 quarters · filed 2021-05-05 | $1.20M derived: sum of 3 quarters · filed 2021-05-05 | $1.90M derived: sum of 4 quarters · filed 2021-05-05 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $300.00K derived: sum of 2 quarters · filed 2021-02-19 | $1.00M derived: sum of 3 quarters · filed 2021-02-19 | -$400.00K 10-K · filed 2021-02-19 |
| 2020-10-02 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.00M derived: sum of 2 quarters · filed 2020-10-29 | -$400.00K 10-Q · filed 2020-10-29 | |
| 2020-07-03 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$700.00K 10-Q · filed 2020-07-30 | ||
| 2020-04-03 | -$1.40M 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DENTSPLY SIRONA Inc. (XRAY) | United States | $1.900B | -3.87 |